Bungum Mona, Spanò Marcello, Humaidan Peter, Eleuteri Patrizia, Rescia Michele, Giwercman Aleksander
Centre of Reproductive Medicine, Malmö University Hospital, 205 02 Malmö, Sweden.
Hum Reprod. 2008 Jan;23(1):4-10. doi: 10.1093/humrep/dem353. Epub 2007 Nov 6.
The sperm chromatin structure assay (SCSA) parameter DNA fragmentation index (DFI) has been shown to predict in vivo and in vitro fertility. So far most SCSA studies have been based on SCSA analysis performed on neat semen. The aim of this study is to assess whether SCSA analysis of sperm prepared by density gradient centrifugation (DGC) could add more information in regard to the prediction of treatment outcome.
The study included 510 assisted reproductive technique (ART) cycles. SCSA was performed in neat semen and post DGC. SCSA results were expressed in terms of DFI and high DNA stainability (HDS) cell fractions. The outcome parameter was clinical pregnancy (CP).
Scatter-plot diagrams demonstrated that for DGC samples, no DFI cut-off values could be set for in vivo or in vitro fertility. In intrauterine insemination, IVF and ICSI groups the mean difference (95% CI) in DFI post DGC between those who achieved CP and those who did not was 0.2% (-1.7 to 2.0%), 0.4% (-1.9 to 2.8%) and 1.3% (-3.1 to 5.9%), respectively, none of these being statistically significant. The corresponding differences for HDS were 0.1% (-1.3 to 1.5%), 0.1% (-0.7 to 0.9%) and 0.6% (-1.6 to 2.7%), respectively (all P-values >0.6).
SCSA performed in semen prepared by DGC cannot predict the outcome of ART.
精子染色质结构分析(SCSA)参数DNA碎片化指数(DFI)已被证明可预测体内和体外受精能力。到目前为止,大多数SCSA研究都是基于对纯精液进行的SCSA分析。本研究的目的是评估对经密度梯度离心(DGC)制备的精子进行SCSA分析是否能在预测治疗结果方面提供更多信息。
该研究纳入了510个辅助生殖技术(ART)周期。对纯精液和DGC处理后的精液进行SCSA分析。SCSA结果以DFI和高DNA染色性(HDS)细胞分数表示。结局参数为临床妊娠(CP)。
散点图显示,对于DGC样本,无法设定体内或体外受精能力的DFI临界值。在宫内人工授精、体外受精和卵胞浆内单精子注射组中,实现临床妊娠者与未实现临床妊娠者之间DGC处理后DFI的平均差异(95%CI)分别为0.2%(-1.7至2.0%)、0.4%(-1.9至2.8%)和1.3%(-3.1至5.9%),均无统计学意义。HDS的相应差异分别为0.1%(-1.3至1.5%)、0.1%(-0.7至0.9%)和0.6%(-1.6至2.7%)(所有P值>0.6)。
对经DGC制备的精液进行SCSA分析无法预测ART的结局。